Esophageal Cancer

Esophageal cancer is a malignant tumor arising from the esophageal mucosa, representing a highly aggressive gastrointestinal malignancy with poor overall prognosis. Two main histologic types exist: squamous cell carcinoma (SCC) and adenocarcinoma (EAC), with distribution varying geographically and by etiology. Globally, esophageal cancer ranks as the sixth leading cause of cancer death, with approximately 17,000 new cases diagnosed annually in the United States and significantly higher incidence in Asia and Africa. The disease typically presents in advanced stages due to the esophagus's distensible nature, allowing tumors to grow substantially before causing obstructive symptoms, resulting in 5-year survival rates of only 15-25% overall. Understanding the distinct epidemiologic patterns, risk factor profiles, and management approaches for SCC versus EAC is essential for clinical practice and board examinations.

Esophageal cancer arises through a multistep process of epithelial transformation involving accumulation of genetic and epigenetic alterations. In squamous cell carcinoma, chronic irritation and inflammation from carcinogens cause repeated cycles of injury and regeneration, progressively promoting dysplastic changes. The critical molecular pathway involves inactivation of p53 and Rb tumor suppressor genes, overexpression of cyclin D1, and disruption of cell cycle checkpoints, allowing uncontrolled proliferation. Human papillomavirus (HPV) integration is increasingly recognized in SCC pathogenesis, particularly in Asian populations, where HPV-16 and HPV-18 E6 and E7 oncoproteins directly inactivate p53 and Rb proteins. Adenocarcinoma develops predominantly through the Barrett's esophagus metaplasia-dysplasia-carcinoma sequence, where chronic gastroesophageal reflux disease (GERD) causes repeated acid injury to the squamous epithelium.

Chronic acid and bile reflux initiates intestinal metaplasia of the distal esophageal squamous epithelium, creating columnar-lined Barrett's esophagus. The metaplastic columnar epithelium, while more resistant to acid injury, becomes increasingly prone to malignant transformation through accumulation of additional oncogenic mutations. Early dysplasia represents low-grade intraepithelial neoplasia with increased but still limited risk of progression. High-grade dysplasia (HGD) carries annual progression rates of 5-10% to invasive carcinoma and represents a critical decision point for intervention. The molecular basis involves sequential p53 mutations, CDX2 transcription factor loss, activation of Wnt/β-catenin signaling, and increased angiogenesis through VEGF overexpression, progressively destabilizing the epithelial barrier and promoting invasion.

Once invasive carcinoma develops, malignant cells breach the basement membrane and invade the submucosa and muscularis propria. Epithelial-to-mesenchymal transition (EMT) is orchestrated by loss of E-cadherin expression and upregulation of SNAIL and TWIST transcription factors, enabling migration and invasion. The esophagus's rich lymphatic network allows rapid dissemination to regional lymph nodes (celiac, left gastric, perihiatal), with lymph node involvement present in up to 50% of cases at diagnosis. Increased lymphangiogenesis, driven by VEGF-C and VEGF-D signaling, promotes tumor spread to distant nodes and organs. Angiogenesis is essential for tumor growth beyond 1-2 mm diameter; hypoxia-inducible factor 1-alpha (HIF-1α) upregulation stimulates VEGF production, creating new blood vessels that support rapid tumor expansion and provide routes for hematogenous dissemination to liver, lung, and bone.

The esophagus's limited distensibility in the tumor-bearing segment progressively narrows the lumen, causing mechanical obstruction to swallowing. Tumor ulceration exposes submucostal vessels, resulting in hemorrhage; invasion into the gastric cardia or pylorus impairs gastric emptying. Direct invasion into the left recurrent laryngeal nerve (which ascends along the aortic arch in the posterior mediastinum) causes hoarseness. Fistula formation between esophagus and airway (tracheoesophageal fistula) occurs with advanced tumors, presenting as severe cough with swallowing. Tumor cachexia results from increased production of proinflammatory cytokines (TNF-α, IL-6), anorexia, and malabsorption from esophageal obstruction, causing progressive weight loss and functional decline.

GERD is the primary risk factor for adenocarcinoma, accounting for 80-90% of EAC cases in Western populations. Prolonged acid exposure (typically >20 years) promotes Barrett's metaplasia; patients with Barrett's esophagus have a 30-40 fold increased risk of EAC compared to the general population. Severity of reflux symptoms correlates with adenocarcinoma risk—those reporting reflux ≥3 times weekly have significantly elevated incidence. Notably, symptomatic GERD burden does not perfectly predict adenocarcinoma risk, as many patients with severe reflux never develop malignancy, suggesting additional cofactors (obesity, smoking, bile reflux) contribute to transformation.

Tobacco smoking increases risk for both SCC and adenocarcinoma through exposure to polycyclic aromatic hydrocarbons (PAHs) and nitrosamines, which generate DNA adducts and free radicals. Alcohol, particularly in high quantities (>100 g/day), is strongly associated with SCC through local mucosal damage and impaired antioxidant defenses. The combination of smoking and heavy alcohol use shows multiplicative (not additive) risk increase, with relative risk reaching 40-100 fold for SCC in heavy users. Alcohol likely acts as a solvent, enhancing carcinogen penetration into epithelial cells, and may inhibit DNA repair mechanisms.

Obesity independently increases adenocarcinoma risk through multiple mechanisms: increased intragastric pressure promoting reflux, adipose tissue-derived inflammatory cytokines (IL-6, TNF-α), and elevated circulating estrogen levels from peripheral aromatization in adipose tissue. Body mass index (BMI) >30 kg/m² carries approximately 1.5-2.0 fold increased risk. Paradoxically, SCC risk may be inversely associated with obesity in some populations, suggesting distinct pathophysiology.

HPV-16 and HPV-18 are detected in 20-60% of esophageal SCC cases globally, with higher prevalence in Asian and African populations. HPV seropositivity correlates with increased SCC risk, and viral integration disrupts normal cell cycle regulation. However, HPV's role as a necessary versus sufficient cause remains unclear; most HPV-infected individuals never develop esophageal cancer, indicating cofactors are essential.

Accidental or intentional caustic (lye, strong acid) ingestion causes acute esophageal injury followed by cicatricial stricture formation. Long-standing caustic strictures (>10-15 years) carry 30-40% risk of SCC development, likely due to chronic irritation, impaired swallowing, and stasis. Achalasia, characterized by failure of lower esophageal sphincter (LES) relaxation, causes prolonged food stasis, repeated microtrauma, and increased SCC risk (30-40 fold elevation), though absolute incidence remains modest.

High consumption of processed meat, salted foods, and foods contaminated with N-nitroso compounds correlates with SCC incidence, particularly in high-risk regions (China, Iran). Conversely, diets rich in fresh vegetables and fruits containing antioxidants (vitamins C, E, selenium, beta-carotene) show protective associations. Iron and zinc deficiency impair epithelial regeneration and immune function, increasing SCC susceptibility in some populations.

Familial keratosis palmaris et plantaris (tylosis), a rare autosomal dominant syndrome caused by RHBDF2 gene mutations, confers >95% lifetime risk of esophageal SCC by age 70. Affected individuals show increased keratin accumulation and abnormal epithelial differentiation, making this one of the highest-risk conditions for esophageal malignancy.

The "esophageal cancer belt" extending from northern China through Central Asia to southern Africa shows dramatically elevated incidence (100-200 cases/100,000 person-years), attributed to combinations of HPV prevalence, dietary practices, micronutrient deficiency, and possibly environmental carcinogens. Iranian populations show extraordinarily high SCC rates linked to opium smoking and unique dietary exposures.

Achalasia (30-40 fold risk increase), prior head and neck SCC (field cancerization with shared carcinogen exposure), immunosuppression (HIV/AIDS, transplant recipients), radiation therapy to the chest (latency 10-20 years), and previous esophageal caustic injury all carry elevated risk for secondary esophageal malignancy.

Dysphagia is the most common presenting symptom, occurring in >90% of patients at diagnosis. The mechanism involves mechanical obstruction from the intraluminal mass narrowing the esophageal lumen, with symptoms typically beginning with solid food dysphagia and progressing to liquid dysphagia as luminal narrowing advances. Dysphagia often develops insidiously over weeks to months, with patients adapting by eating more slowly, chewing thoroughly, or consuming softer foods—subtle changes that may delay presentation. The specific character can provide anatomic clues: tumors of the mid-esophagus classically present with dysphagia to solids; proximal tumors may cause oropharyngeal dysphagia with difficulty initiating swallowing. Unlike achalasia (which typically presents with dysphagia to both solids and liquids equally), or peptic strictures (which show more gradual progression over years), esophageal cancer dysphagia is typically progressive over months and associated with constitutional symptoms.

Pain with swallowing occurs in 30-40% of patients and results from tumor ulceration exposing submucosal nerve endings and invasive tumor irritating esophageal innervation. Odynophagia often localizes to the retrosternal region and may be accompanied by substernal chest pain that worsens with swallowing. This symptom typically indicates more advanced local disease with significant ulceration or full-thickness invasion.

Unintentional weight loss (often >10 kg) occurs in 60-75% of patients at presentation, reflecting a combination of reduced oral intake due to dysphagia, tumor-induced cachexia from elevated cytokine production (TNF-α, IL-6), and increased metabolic demands from malignancy. Weight loss is often progressive and substantial by the time of diagnosis, with many patients having lost 20-30% of baseline body weight. Nutritional depletion impairs immunity, wound healing, and tolerance of multimodal therapy, making nutritional assessment critical at presentation.

Hoarseness occurs in 5-18% of patients, indicating left recurrent laryngeal nerve (LRLN) involvement by tumors of the middle and lower esophagus. The LRLN ascends in the posterior mediastinum along the aortic arch, and tumors at the left mainstem bronchus level or those directly invading the left mediastinum can compress or invade this nerve. Hoarseness may be the initial presenting symptom before dysphagia becomes severe and should always raise suspicion for esophageal or gastric cardia malignancy. Complete vocal cord paralysis results in breathy voice quality and weak cough, while partial paralysis causes hoarse, breathy dysphonia.

Cough, especially with swallowing or drinking liquids, occurs in 5-10% of patients and results from tumor proximity to the trachea and carina. Cough may indicate tracheoesophageal fistula (TEF) formation, a grave complication where tumor invades the posterior esophageal wall into the adjacent trachea. TEF presents with severe paroxysmal cough triggered by swallowing, aspiration of food and saliva into the airways, and recurrent pneumonia. The presence of pneumonia with esophageal cancer should raise concern for TEF.

Retrosternal or thoracic pain develops in 20-50% of patients, reflecting tumor invasion into mediastinal structures, visceral pleura, or thoracic vertebral bodies. Severe back pain suggests posterior mediastinal involvement or vertebral invasion. Unlike anginal chest pain, esophageal cancer pain is typically constant, progressive, and not relieved by rest or nitrates.

Bleeding occurs in 10-30% of patients, manifesting as hematemesis, melena, or positive fecal occult blood testing. Tumor ulceration erodes into submucosal vessels, causing acute or chronic hemorrhage. Massive hematemesis is uncommon but represents a medical emergency requiring urgent intervention. Chronic occult bleeding contributes to iron-deficiency anemia.

Persistent hiccups are an unusual but specific symptom indicating diaphragmatic irritation from lower esophageal or gastric cardia tumors. This symptom often precedes other complaints and may be dismissed by patients and clinicians, delaying diagnosis.

Patients with advanced stage disease may present with manifestations of distant metastases: abdominal pain and jaundice from liver metastases, bone pain from osseous involvement, neurologic symptoms from brain metastases, or dyspnea from pulmonary involvement or malignant pleural effusion. Approximately 40% of patients have metastatic disease at presentation.

Early-stage esophageal cancer: Occasionally detected incidentally during surveillance endoscopy in Barrett's esophagus patients or during evaluation of dyspepsia; these patients may be asymptomatic or have only mild, intermittent symptoms.

Very proximal (cervical) tumors: May present with dysphagia to solids more severe than expected, cervical pain, or stridor if significant narrowing or obstruction develops.

Cardia tumors: Gastric cardia malignancies extending into the distal esophagus present with epigastric pain, early satiety, or vomiting rather than pure dysphagia, and are often initially misattributed to gastric ulcer disease.

The diagnostic approach begins with characterization of dysphagia onset, progression rate, and associated symptoms. Key historical features include duration of symptoms (typically weeks to months before presentation), severity (affecting ability to swallow saliva, liquids, or solids only), weight loss magnitude and timeline, presence of constitutional symptoms (fever, night sweats), prior reflux history, smoking/alcohol use, and prior caustic exposures. A detailed dietary history and assessment of how symptoms have modified eating habits helps establish disease severity. Red flag symptoms—hoarseness, chest pain, hematemesis, cough—should elevate suspicion for advanced disease.

Endoscopy is the gold standard diagnostic test for esoph